Patients who experienced the first-ever outcome prior to the start of follow-up were excluded from the analysis of that outcome (although such patients could be included into the analyses of other outcomes).
For both combined micro- and macroangiopathy outcomes, SMBG was not associated with a first ever event in the 5-year longitudinal cohort in either unadjusted or adjusted models, with or without time-dependent analyses.
We defined incidence as the patient's first ever event.
PP independently predicted a first ever CVD event.
Of those, 178 had their first ever CVD event.
This article reports on the first ever study to assess the clinical outcome of nosocomial pneumonia caused by a range of different serotypes of P. aeruginosa in critically ill patients under standard ICU management.
A further strength of this study was access to clinical data, which resulted in the first ever investigation of pregnancy and birth outcomes in relation to age at MS onset, disease duration, and disability.
As primary outcomes we used: 1) Incidence of first ever dispensed inhaled β2-agonist.
Our study represents the first ever report of the impact of EBV on the clinical outcome of BC patients, regardless of tumor histology or treatment regimen.
